Evidence map›Paper›PMID 25878350›Full record

ArticleJournal of clinical microbiology2015

Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.

S W Peterson, I Martin, W Demczuk, A Bharat, L Hoang, J Wylie, V Allen, B Lefebvre, G Tyrrell, G Horsman and 4 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Resistance-Guided Therapy for Neisseria gonorrhoeae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. The Laboratory Diagnosis ofPathogens (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2019
    Article
  16. Multidrug-resistant and extensively drug-resistantCanada communicable disease report = Releve des maladies transmissibles au Canada · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Gonorrhea in Canada, 2010-2015.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

S W PetersonBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
I MartinBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
W DemczukBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
A BharatBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
L HoangBritish Columbia Centres for Disease Control Public Health Microbiology and Reference Laboratory, Vancouver, British Columbia, Canada.
J WylieCadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
V AllenPublic Health Ontario Laboratories, Toronto, Ontario, Canada.
B LefebvreLaboratoire de Santé Publique du Québec, Ste-Anne-De-Bellevue, Québec, Canada.
G TyrrellProvincial Laboratory for Public Health, Edmonton, Alberta, Canada.
G HorsmanSaskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.
D HaldaneQueen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
R GarceauDr. G.L. Dumont Hospital, Moncton, New Brunswick, Canada.
T WongCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
M R MulveyBacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada michael.mulvey@phac-aspc.gc.ca.
Public Health Agency of Canada · CABC Centre for Disease Control · CADr. Georges-L.-Dumont University Hospital Centre · CAProvincial Laboratory of Public Health · CAQueen Elizabeth II Health Sciences Centre · CASaskatchewan Disease Control Laboratory · CASte. Anne's Hospital · CAToronto Public Health · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of antimicrobial-resistant Neisseria gonorrhoeae continues to rise in Canada; however, antimicrobial resistance data are lacking for approximately 70% of gonorrhea infections that are diagnosed directly from clinical specimens by nucleic acid amplification tests (NAATs). We developed a molecular assay for surveillance use to detect mutations in genes associated with decreased susceptibility to cephalosporins that can be applied to both culture isolates and clinical samples. Real-time PCR assays were developed to detect single nucleotide polymorphisms (SNPs) in ponA, mtrR, penA, porB, and one N. gonorrhoeae-specific marker (porA). We tested the real-time PCR assay with 252 gonococcal isolates, 50 nongonococcal isolates, 24 N. gonorrhoeae-negative NAAT specimens, and 34 N. gonorrhoeae-positive NAAT specimens. Twenty-four of the N. gonorrhoeae-positive NAAT specimens had matched culture isolates. Assay results were confirmed by comparison with whole-genome sequencing data. For 252 N. gonorrhoeae strains, the agreement between the DNA sequence and real-time PCR was 100% for porA, ponA, and penA, 99.6% for mtrR, and 95.2% for porB. The presence of ≥2 SNPs correlated with decreased susceptibility to ceftriaxone (sensitivities of >98%) and cefixime (sensitivities of >96%). Of 24 NAAT specimens with matched cultures, the agreement between the DNA sequence and real-time PCR was 100% for porB, 95.8% for ponA and mtrR, and 91.7% for penA. We demonstrated the utility of a real-time PCR assay for sensitive detection of known markers for the decreased susceptibility to cephalosporins in N. gonorrhoeae. Preliminary results with clinical NAAT specimens were also promising, as they correlated well with bacterial culture results.

Indexed as

Drug Resistance, BacterialGenetic MarkersAnti-Bacterial AgentsCanadaCephalosporinsFemaleGenes, BacterialGenotyping TechniquesGonorrheaHumansMaleMicrobiological TechniquesNeisseria gonorrhoeaePolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionSensitivity and SpecificityAnti-Bacterial AgentsCephalosporinsGenetic Markers

Identifiers

PMID25878350
PMCPMC4473228
OpenAlexW2025722365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.